Nabil Saba, MD, FACP

One star
One star
One star
One star
One half star

Rating: 4.6 out of 5 (248 ratings)

Role

Medical Oncology
Specialty

Head and Neck Cancer Esophageal Cancer Thyroid Cancer Lung Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

1999

Call 404-778-0278

Background

Nabil F. Saba, MD, FACP, is an internationally recognized expert in the treatment of head and neck cancers. Dr. Saba is professor and vice chair in the Department of Hematology and Medical Oncology, and the Inaugural Lynne and Howard Halpern Chair in Head and Neck Cancer Research. He holds a joint appointment as professor in the Department of Otolaryngology at Emory University School of Medicine. He serves as director of the Head and Neck Cancer Medical Oncology Program and is co-leader of the Multidisciplinary Head and Neck Program at Winship Cancer Institute of Emory University.

Dr. Saba is a well-recognized expert in immunotherapy for head and neck cancer and upper aero-digestive malignancies. His work is focused on translational research and the study and development of novel therapeutic agents and modalities in these diseases. He has been principal investigator in more than 50 clinical trials and chairs national as well as investigator initiated multi-institution studies focusing on novel approaches for treating head and neck and esophageal cancer. Dr Saba has been instrumental in establishing the head and neck cancer research working group at Winship Cancer Institute and is the contact principal investigator of the Lead Academic Participating Site (LAPS) grant of the NCI’s National Clinical Trials Network (NCTN).

Dr. Saba has been elected for two terms as chair and chair emeritus of the National Cancer Institute's task force for recurrent metastatic head and neck cancer, and chaired the Rare Tumors Task Force of the National Cancer Institute's Head and Neck Cancer Steering Committee. He is an active member of the NRG Oncology and Eastern Cooperative Oncology Group Head and Neck Cancer Core Committees, and chairs two NCI cooperative group trials in the field of head and neck oncology under the ECOG-ACRIN group. Dr Saba has received competitive NIH funding investigating novel genomic approaches in HPV related and unrelated OPCA and is the recipient of intramural funding studying this disease. He has published more than 290 peer reviewed manuscripts and textbook chapters and is editor of two textbooks : “Esophageal Cancer: Prevention, Diagnosis and Therapy” published in two editions and “Sino-Nasal and Skull Base Malignancies”. He is associate editor of JNCI, and Head Neck and served as a member of the ASCO Guidelines Committee.

Dr. Saba earned his Medical Degree from the American University of Beirut Medical School. He completed a Residency in Internal Medicine at Tufts University School of Medicine in Boston, and a Clinical Fellowship in Hematology and Oncology at Brown University School of Medicine. He subsequently completed a Bone Marrow Transplant Fellowship at the University of Toronto Princess Margaret Hospital in Toronto, Canada.

Play Video

Titles & Roles

Professor and Vice Chair for Quality and Safety, Department of Hematology and Medical Oncology

Emory University School of Medicine
Inaugural Lynne and Howard Halpern Chair in Head and Neck Cancer Research

Winship Cancer Institute of Emory University
Adjunct Professor, Department of Otolaryngology

Emory University School of Medicine
Co-Director, Head and Neck Cancer Multidisciplinary Program

Winship Cancer Institute of Emory University

Education & Training

Education

Fellowship, Medical Oncology, 1999
Princess Margaret Hosp-CAN
Fellowship, Hematology & Oncology, 1997
Brown University
Residency, Internal Medicine, 1994
Faulkner Hospital
Internship, Internal Medicine, 1992
Univ. of Wisconsin - Madison
Medical Education, MD, 1990
American University of Beirut

Board Certifications

Medical Oncology
American Board of Internal Medicine, 1997
Hematology
American Board of Internal Medicine, 1997

Professional Memberships

American Head and Neck Cancer Society
American College of Radiology (Head and Neck Panel)
American College of Physicians, Fellow
American Society of Clinical Oncology
European Society of Clinical Oncology
Massachusetts Medical Society

Research

Dr. Saba's research is focused on clinical and translational work in head and neck, and esophageal cancer. He has been the recipient of several NIH and industry funded grant support to study these malignancies. He has received funding from the NIH to examine novel genomic approaches for diagnosing HPV positive oropharyngeal cancers.

Among Dr Saba's contributions is serving as a co-leader of the previously funded Emory Head and Neck Cancer SPORE and serving as a Principal Investigator of the recently submitted Emory Head and Neck Cancer SPORE grant.

Clinical Trials

Dr. Saba conducts and leads a number of head and neck cancer clinical trials with a focus on biomarker endpoints including two cooperative group studies.

View Current Clinical Trials


Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Phase II/III Conditions Head and Neck Squamous Cell Carcinoma Location Emory University Hospital Midtown
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma Phase III Conditions Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Location Emory University Hospital Midtown, Winship Cancer Institute
Study of CHS-114 in Participants With Advanced Solid Tumors Phase I Conditions Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Location Emory University Hospital Midtown
Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC Phase II Conditions HNSCC Location Emory University Hospital Midtown
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers Phase II/III Conditions Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Lip and Oral Cavity Carcinoma, Metastatic Nasal Cavity Squamous Cell Carcinoma, Metastatic Nasopharyngeal Squamous Cell Carcinoma, Metastatic Pharyngeal Squamous Cell Carcinoma, Metastatic Sinonasal Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Lip and Oral Cavity Squamous Cell Carcinoma, Recurrent Nasopharyngeal Squamous Cell Carcinoma, Recurrent Pharyngeal Squamous Cell Carcinoma, Recurrent Sinonasal Squamous Cell Carcinoma, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Sinonasal Cancer AJCC v8 Location Emory University Hospital Midtown, Winship Cancer Institute
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 Phase II Conditions Unresectable Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Cancer, Recurrent Head and Neck Cancer Location Emory University Hospital Midtown, Winship Cancer Institute
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery Phase II Conditions Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant, Lip and Oral Cavity Squamous Cell Carcinoma, p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma, Stage III Hypopharyngeal Carcinoma AJCC v8, Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage III Oral Cavity Verrucous Carcinoma, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVA Hypopharyngeal Carcinoma AJCC v8, Stage IVA Laryngeal Cancer AJCC v8, Stage IVA Lip and Oral Cavity Cancer AJCC v8, Stage IVA Oral Cavity Verrucous Carcinoma, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Location Emory University Hospital Midtown, Winship Cancer Institute

Grants

View Grants

Grant Number	Title
5UG1CA233247-03	Winship National Clinical Trials Network Lead Academic Participating Site
5UG1CA233247-04	Winship National Clinical Trials Network Lead Academic Participating Site
5UG1CA233247-05	Winship National Clinical Trials Network Lead Academic Participating Site
5UG1CA233247-06	Winship National Clinical Trials Network Lead Academic Participating Site

Publications

Dr. Saba has authored more than 150 multiple peer-reviewed articles, editorials, review papers, book chapters as well as two Uptodate chapters. He is the editor of the textbook, "Esophageal Cancer, Prevention, Diagnosis and Treatment" which was published in two editions, and of the textbook, "Sinonasal and Skull Base Malignancies." He is associate editor for Head Neck, associate editor for Journal of the National Cancer Institute, and a member of the editorial board of Cancer, Oral Oncology, and American Journal of Clinical Oncology. He has been recognized as an outstanding reviewer for the journal, Cancer.

Title/Journal	Authors	Publication Date
A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis. The Laryngoscope	SR Best, JM Bock, NB Fowler, EH Raabe, AM Klein, TW Laetsch, K McClellan, RNPM Rinkel, NF Saba, DR Sidell, JB Tansey, DE Tunkel, GD Young, KB Zur	12/01/2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research	NF Saba, R Chaudhary, K Kirtane, A Marra, A Ekpenyong, A McCook-Veal, NC Schmitt, JH Gross, MR Patel, J Remick, JE Bates, MW McDonald, SF Rudra, WA Stokes, M Biernacki, X Song, RJC Slebos, Y Liu, CE Steuer, DM Shin, Y Teng, CH Chung	10/15/2024
Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer. Cancer research	J Yang, F Chen, L Lang, F Yang, Z Fu, J Martinez, A Cho, NF Saba, Y Teng	10/01/2024
Risk stratification of ThyroSeq results in indeterminate thyroid lesions: A single-institution experience of clinicopathologic correlation with cytologic findings. Cancer cytopathology	WY Hsiao, NF Saba, D Lubin, A Chen, Q Shi	09/19/2024
Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage. Head & neck	S Pamulapati, M Abousaud, Y Li, A Ekpenyong, S Rudra, JS Remick, JE Bates, WA Stokes, MW McDonald, NC Schmitt, MW El-Deiry, MR Patel, CE Steuer, JM Switchenko, DM Shin, Y Teng, A Hammond, NF Saba	09/01/2024
Exploring the impact of GSTM1 as a novel molecular determinant of survival in head and neck cancer patients of African descent. Journal of experimental & clinical cancer research : CR	F Yang, F Chen, C Shay, GZ Chen, NF Saba, Y Teng	07/23/2024
DNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism. Molecular psychiatry	C Xiao, G Peng, KN Conneely, H Zhao, JC Felger, EC Wommack, KA Higgins, DM Shin, NF Saba, DW Bruner, AH Miller	07/09/2024
ThyroSeq overview on indeterminate thyroid nodules: An institutional experience. Diagnostic cytopathology	S Sirotnikov, CC Griffith, D Lubin, C Zhang, NF Saba, D Li, A Kornfield, A Chen, Q Shi	07/01/2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial. JAMA oncology	NF Saba, SJ Wong, T Nasti, AA McCook-Veal, MW McDonald, WA Stokes, AM Anderson, A Ekpenyong, M Rupji, M Abousaud, S Rudra, JE Bates, JS Remick, NP Joshi, NM Woody, M Awan, JL Geiger, A Shreenivas, J Samsa, MC Ward, NC Schmitt, MR Patel, KA Higgins, Y Teng, CE Steuer, DM Shin, Y Liu, R Ahmed, SA Koyfman	07/01/2024
Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer. Journal of experimental & clinical cancer research : CR	F Yang, C Yuan, F Chen, ZS Qin, NC Schmitt, GB Lesinski, NF Saba, Y Teng	03/12/2024
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science advances	F Chen, C Tang, F Yang, A Ekpenyong, R Qin, J Xie, F Momen-Heravi, NF Saba, Y Teng	02/23/2024
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trials. Cancer	AW Walter, JW Lee, JM Streck, IF Gareen, BA Herman, SM Kircher, RC Carlos, SK Kumar, IA Mayer, NF Saba, TS Fenske, JW Neal, MB Atkins, FS Hodi, CE Kyriakopoulos, CM Tempany-Afdhal, TD Shanafelt, LI Wagner, SR Land, JS Ostroff, ER Park	02/01/2024
Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement. The Laryngoscope	RJ So, JC Hidalgo Lopez, SA Ballestas, AM Klein, C Steuer, DM Shin, M Abousaud, Y Teng, NF Saba, AT Tkaczuk, ES Schaefer, TY Seiwert, K McClellan, SR Best	02/01/2024
Cancer metabolism and carcinogenesis. Experimental hematology & oncology	J Yang, C Shay, NF Saba, Y Teng	01/29/2024
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53. Cancer immunology, immunotherapy : CII	BLC Kinney, S Gunti, V Kansal, CJ Parrish, NF Saba, Y Teng, MK Henry, FY Su, GA Kwong, NC Schmitt	01/17/2024
CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescent. Oncoimmunology	BLC Kinney, B Brammer, V Kansal, CJ Parrish, HT Kissick, Y Liu, NF Saba, ZS Buchwald, MW El-Deiry, MR Patel, BJ Boyce, AS Kaka, JH Gross, HM Baddour, AY Chen, NC Schmitt	01/01/2024
Associations of differentially expressed genes with psychoneurological symptoms in patients with head and neck cancer: A longitudinal study. Journal of psychosomatic research	Y Lin, G Peng, DW Bruner, AH Miller, NF Saba, KA Higgins, DM Shin, H Claussen, HR Johnston, MC Houser, EC Wommack, C Xiao	12/01/2023
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial. JAMA oncology	SJ Wong, PA Torres-Saavedra, NF Saba, G Shenouda, JM Bumpous, RE Wallace, CH Chung, AK El-Naggar, CK Gwede, B Burtness, PA Tennant, NE Dunlap, R Redman, WA Stokes, S Rudra, LK Mell, AG Sacco, SA Spencer, L Nabell, M Yao, FL Cury, DL Mitchell, CU Jones, S Firat, JN Contessa, T Galloway, A Currey, J Harris, WJ Curran, QT Le	11/01/2023
Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory Papillomatosis. The Laryngoscope	T Mau, MR Amin, PC Belafsky, SR Best, AD Friedman, AM Klein, DG Lott, RC Paniello, SM Pransky, NF Saba, T Howard, M Dallas, A Patel, MP Morrow, JM Skolnik	11/01/2023
Iron, Ferroptosis, and Head and Neck Cancer. International journal of molecular sciences	Y Teng, L Gao, AA Mäkitie, E Florek, A Czarnywojtek, NF Saba, A Ferlito	10/12/2023
Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study. Brain, behavior, and immunity	C Xiao, V Fedirko, H Claussen, H Richard Johnston, G Peng, S Paul, KM Maner-Smith, KA Higgins, DM Shin, NF Saba, EC Wommack, DW Bruner, AH Miller	10/01/2023
Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis. The Laryngoscope	SA Ballestas, J Hidalgo Lopez, AM Klein, C Steuer, DM Shin, M Abousaud, NC Schmitt, Y Teng, NF Saba, AT Tkaczuk	10/01/2023
Longitudinal associations among physical activity, inflammatory markers, and quality of life in patients with head and neck cancer. Head & neck	S Huang, Y Zhan, S Jeon, DW Bruner, AH Miller, JC Felger, EC Wommack, NF Saba, KA Higgins, ML Irwin, RA Gary, C Xiao	08/01/2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	JE Bauman, NF Saba, D Roe, JR Bauman, J Kaczmar, A Bhatia, J Muzaffar, R Julian, S Wang, S Bearelly, A Baker, C Steuer, A Giri, B Burtness, S Centuori, C Caulin, R Klein, K Saboda, S Obara, CH Chung	08/01/2023
Associations of inflammation with neuropsychological symptom cluster in patients with Head and neck cancer: A longitudinal study. Brain, behavior, & immunity - health	Z Amirkhanzadeh Barandouzi, DW Bruner, AH Miller, S Paul, JC Felger, EC Wommack, KA Higgins, DM Shin, NF Saba, C Xiao	07/01/2023
The expanding role of IAP antagonists for the treatment of head and neck cancer. Cancer medicine	V Kansal, BLC Kinney, S Uppada, NF Saba, WA Stokes, ZS Buchwald, NC Schmitt	07/01/2023
Patient-reported outcomes in immunotherapy for head and neck cancer. Head & neck	K Kirtane, AI Hoogland, X Li, Y Rodriguez, K Scheel, BJ Small, LB Oswald, J Muzaffar, JA Kish, M Bonomi, P Bhateja, NF Saba, CE Steuer, CH Chung, HSL Jim	07/01/2023
Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic Subtypes. Cancers	RC Eldridge, ZS Qin, NF Saba, MC Houser, DN Hayes, AH Miller, DW Bruner, DP Jones, C Xiao	06/14/2023
Insurance Authorization and Access to Proton Therapy for Patients With Head and Neck Cancers. International journal of radiation oncology, biology, physics	MW McDonald, JE Bates, NS McCall, S Goyal, Y Liu, S Rudra, JS Remick, S Tian, MW El-Deiry, NF Saba, WA Stokes, E Swinney	06/01/2023
Recurrent Differentiated Thyroid Cancer: The Current Treatment Options. Cancers	A Coca-Pelaz, JP Rodrigo, JP Shah, IJ Nixon, DM Hartl, KT Robbins, LP Kowalski, AA Mäkitie, M Hamoir, F López, NF Saba, S Nuyts, A Rinaldo, A Ferlito	05/10/2023
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	RI Haddad, K Harrington, M Tahara, RL Ferris, M Gillison, J Fayette, A Daste, P Koralewski, B Zurawski, M Taberna, NF Saba, M Mak, A Kawecki, G Girotto, MA Alvarez Avitia, C Even, JGR Toledo, A Guminski, U Müller-Richter, N Kiyota, M Roberts, TA Khan, K Miller-Moslin, L Wei, A Argiris	04/20/2023
Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer. Cancer research communications	L Lang, F Chen, Y Li, C Shay, F Yang, H Dan, ZG Chen, NF Saba, Y Teng	04/01/2023
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood. International journal of radiation oncology, biology, physics	DC Qian, BC Ulrich, G Peng, H Zhao, KN Conneely, AH Miller, DW Bruner, RC Eldridge, EC Wommack, KA Higgins, DM Shin, NF Saba, AK Smith, B Burtness, HS Park, WA Stokes, JJ Beitler, C Xiao	04/01/2023
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline Q and A. JCO oncology practice	E Yilmaz, N Ismaila, R Dabney, NF Saba, LK Mell	04/01/2023
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial. Nature medicine	NF Saba, CE Steuer, A Ekpenyong, A McCook-Veal, K Magliocca, M Patel, NC Schmitt, W Stokes, JE Bates, S Rudra, J Remick, M McDonald, M Abousaud, AC Tan, MZH Fadlullah, R Chaudhary, J Muzaffar, K Kirtane, Y Liu, GZ Chen, DM Shin, Y Teng, CH Chung	04/01/2023
Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer. Cancers	NF Saba, S Pamulapati, B Patel, M Mody, P Strojan, R Takes, AA Mäkitie, O Cohen, P Pace-Asciak, JB Vermorken, C Bradford, A Forastiere, Y Teng, A Wieland, A Ferlito	03/24/2023
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504. International journal of radiation oncology, biology, physics	ML Gillison, RL Ferris, J Harris, AD Colevas, LK Mell, C Kong, RC Jordan, KL Moore, MT Truong, C Kirsch, A Chakravarti, DM Blakaj, DA Clump, JP Ohr, JF Deeken, MF Gensheimer, NF Saba, JA Dorth, DI Rosenthal, RS Leidner, RJ Kimple, M Machtay, WJ Curran, P Torres-Saavedra, QT Le	03/15/2023
Radiomics in Hypopharyngeal Cancer Management: A State-of-the-Art Review. Biomedicines	CM Chiesa-Estomba, M Mayo-Yanez, O Guntinas-Lichius, V Vander-Poorten, RP Takes, R de Bree, GB Halmos, NF Saba, S Nuyts, A Ferlito	03/06/2023
Biomarkers predictive of response to pembrolizumab in head and neck cancer. Cancer medicine	DG Pfister, RI Haddad, FP Worden, J Weiss, R Mehra, LQM Chow, SV Liu, H Kang, NF Saba, LJ Wirth, A Sukari, E Massarelli, M Ayers, A Albright, AL Webber, R Mogg, J Lunceford, L Huang, R Cristescu, J Cheng, TY Seiwert, JM Bauml	03/01/2023
Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilities. Head & neck	JR Janopaul-Naylor, M Rupji, RA Tobillo, JW Lorenz, JM Switchenko, S Tian, AS Kaka, DC Qian, AJ Schlafstein, CE Steuer, JS Remick, S Rudra, MW McDonald, NF Saba, WA Stokes, MR Patel, JE Bates	03/01/2023
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	E Yilmaz, N Ismaila, JE Bauman, R Dabney, G Gan, R Jordan, M Kaufman, K Kirtane, SM McBride, MO Old, L Rooper, NF Saba, S Sheth, RM Subramaniam, TM Wise-Draper, D Wong, LK Mell	02/10/2023
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research	C Aggarwal, NF Saba, A Algazi, A Sukari, TY Seiwert, M Haigentz, M Porosnicu, M Bonomi, J Boyer, MT Esser, LI Cheng, S Agrawal, EC Jennings, NM Durham, K Fraser, D Lissa, M Gong, N Ceaicovscaia, A Gascó Hernández, R Kumar	02/01/2023
Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States. Journal of experimental & clinical cancer research : CR	F Yang, C Shay, M Abousaud, C Tang, Y Li, Z Qin, NF Saba, Y Teng	01/05/2023
The evolving landscape of salivary gland tumors. CA: a cancer journal for clinicians	CE Steuer, GJ Hanna, K Viswanathan, JE Bates, AS Kaka, NC Schmitt, AL Ho, NF Saba	01/01/2023
Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck. Frontiers in oncology	P Puttagunta, SV Pamulapati, JE Bates, JH Gross, WA Stokes, NC Schmitt, C Steuer, Y Teng, NF Saba	01/01/2023
Oncologic Outcomes After Clinically Node-Negative Salvage Laryngectomy. JAMA otolaryngology-- head & neck surgery	JH Gross, MR Patel, JM Switchenko, TG Chan, HM Baddour, A Kaka, BJ Boyce, NF Saba, JJ Beitler, M El-Deiry	01/01/2023
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models. Journal for immunotherapy of cancer	V Kansal, AJ Burnham, BLC Kinney, NF Saba, C Paulos, GB Lesinski, ZS Buchwald, NC Schmitt	01/01/2023
Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: "Repeat and replicate". Cancer	CE Steuer, NF Saba	12/15/2022
Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Journal of the National Cancer Institute	CP Rodriguez, H Kang, JL Geiger, B Burtness, CH Chung, CR Pickering, C Fakhry, QT Le, SS Yom, TJ Galloway, E Golemis, A Li, J Shoop, S Wong, R Mehra, H Skinner, NF Saba, ER Flores, JN Myers, JM Ford, R Karchin, RL Ferris, C Kunos, JM Lynn, S Malik	12/08/2022
The impact of operability status on outcomes in patients with T4 larynx cancer undergoing larynx preservation. Head & neck	AJ Schlafstein, S Goyal, A Amini, SD Karam, NF Saba, AS Kaka, AH Aiken, JJ Beitler, WA Stokes	12/01/2022
Current Radiotherapy Considerations for Nasopharyngeal Carcinoma. Cancers	WT Ng, JCH Chow, JJ Beitler, J Corry, W Mendenhall, AWM Lee, KT Robbins, S Nuyts, NF Saba, R Smee, WA Stokes, P Strojan, A Ferlito	11/24/2022
Evaluating new treatments for anaplastic thyroid cancer. Expert review of anticancer therapy	A Coca-Pelaz, JP Rodrigo, F Lopez, JP Shah, CE Silver, A Al Ghuzlan, CW Menke-van der Houven van Oordt, RC Smallridge, AR Shaha, P Angelos, WM Mendenhall, C Piazza, KD Olsen, J Corry, RP Tufano, A Sanabria, S Nuyts, CA Nathan, V Vander Poorten, FL Dias, C Suarez, NF Saba, P de Graaf, MD Williams, A Rinaldo, A Ferlito	11/01/2022
The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss. Journal of the National Cancer Institute	CS Lalonde, Y Teng, BA Burtness, RL Ferris, R Ahmed, NF Saba	10/06/2022
A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy. Cancer	Y Lin, DW Bruner, S Paul, AH Miller, NF Saba, KA Higgins, DM Shin, W Zhang, C Miaskowski, C Xiao	10/01/2022
The diverse functions of FAT1 in cancer progression: good, bad, or ugly? Journal of experimental & clinical cancer research : CR	ZG Chen, NF Saba, Y Teng	08/15/2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research	CH Chung, J Li, CE Steuer, P Bhateja, M Johnson, J Masannat, MI Poole, F Song, JC Hernandez-Prera, H Molina, BM Wenig, S Kumar, C Kuperwasser, PJ Stephens, JM Farinhas, DM Shin, JA Kish, J Muzaffar, K Kirtane, JW Rocco, MJ Schell, NF Saba, M Bonomi	06/01/2022
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma. Journal for immunotherapy of cancer	X Wang, J Muzaffar, K Kirtane, F Song, M Johnson, MJ Schell, J Li, SJ Yoder, JR Conejo-Garcia, JA Guevara-Patino, M Bonomi, P Bhateja, JW Rocco, CE Steuer, NF Saba, CH Chung	06/01/2022
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer. Cancers	JE Bauman, Z Chen, C Zhang, JP Ohr, RL Ferris, GM McGorisk, S Brandt, S Srivatsa, AY Chen, CE Steuer, DM Shin, NF Saba, FR Khuri, TK Owonikoko	05/26/2022
Epidemiology of early esophageal adenocarcinoma. Clinical endoscopy	TP Hang, Z Spiritos, AM Gamboa, Z Chen, S Force, V Patel, S Chawla, S Keilin, NF Saba, B El-Rayes, Q Cai, FF Willingham	05/01/2022
Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab. Oral oncology	DJ Glazar, M Johnson, J Farinhas, CE Steuer, NF Saba, M Bonomi, CH Chung, H Enderling	04/01/2022
Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era. Cancers	NF Saba, P Vijayvargiya, JB Vermorken, JP Rodrigo, SM Willems, N Zidar, R de Bree, A Mäkitie, GT Wolf, A Argiris, Y Teng, A Ferlito	02/25/2022
Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas. The oncologist	P Vijayvargiya, S Trivedi, M Rupji, H Song, Y Liu, R Jiang, AS Kaka, GZ Chen, W Stokes, C Steuer, DM Shin, JJ Beitler, MR Patel, A Aiken, NF Saba	02/03/2022
The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures. Head & neck	VR Dhere, CE Escott, S Tian, JM Switchenko, JP Bell, WA Stokes, MW McDonald, KR Magliocca, BJ Boyce, AS Kaka, CE Steuer, NF Saba, DM Shin, C Xiao, MR Patel, JJ Beitler	02/01/2022
ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development. Journal of experimental & clinical cancer research : CR	L Lang, R Loveless, J Dou, T Lam, A Chen, F Wang, L Sun, J Juarez, ZS Qin, NF Saba, C Shay, Y Teng	01/29/2022
To Scan or Not to Scan: The Dilemma of Posttreatment Imaging Surveillance of Head and Neck Cancer. Practical radiation oncology	JR Janopaul-Naylor, AH Aiken, NF Saba, M El-Deiry, AS Kaka, WA Stokes	01/01/2022
Head and neck cancer. Lancet (London, England)	MD Mody, JW Rocco, SS Yom, RI Haddad, NF Saba	12/18/2021
Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer. Journal of experimental & clinical cancer research : CR	L Lang, F Wang, Z Ding, X Zhao, R Loveless, J Xie, C Shay, P Qiu, Y Ke, NF Saba, Y Teng	12/14/2021
De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed? Oral oncology	P Golusinski, J Corry, VV Poorten, R Simo, E Sjögren, A Mäkitie, LP Kowalski, J Langendijk, BJM Braakhuis, RP Takes, A Coca-Pelaz, JP Rodrigo, SM Willems, AA Forastiere, R De Bree, NF Saba, Y Teng, A Sanabria, P Di Maio, M Szewczyk, A Ferlito	12/01/2021
The Hidden Link of Exosomes to Head and Neck Cancer. Cancers	Y Teng, L Gao, R Loveless, JP Rodrigo, P Strojan, SM Willems, CA Nathan, AA Mäkitie, NF Saba, A Ferlito	11/19/2021
Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC). Oral oncology	L Shu, D Wang, S Nannapaneni, Y Sun, CC Griffith, X Wang, Z Chen, M Patel, M El-Deiry, DM Shin, ZG Chen, NF Saba	11/01/2021
Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	RC Eldridge, K Uppal, DN Hayes, MR Smith, X Hu, ZS Qin, JJ Beitler, AH Miller, EC Wommack, KA Higgins, DM Shin, B Ulrich, DC Qian, NF Saba, DW Bruner, DP Jones, C Xiao	10/01/2021
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study. Cancer	C Xiao, JJ Beitler, G Peng, ME Levine, KN Conneely, H Zhao, JC Felger, EC Wommack, CE Chico, S Jeon, KA Higgins, DM Shin, NF Saba, BA Burtness, DW Bruner, AH Miller	09/15/2021
Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population--A SEER-based analysis from 2000 to 2016. Cancer medicine	MA Taylor, J Switchenko, W Stokes, MR Patel, M McDonald, C Steuer, A Aiken, JJ Beitler, DM Shin, NF Saba	09/01/2021
The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck Cancers. Cancer research	Z Chen, C Zhang, J Chen, D Wang, J Tu, C Van Waes, NF Saba, ZG Chen, Z Chen	09/01/2021
Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer. International journal of radiation oncology, biology, physics	C Xiao, AH Miller, G Peng, ME Levine, KN Conneely, H Zhao, RC Eldridge, EC Wommack, S Jeon, KA Higgins, DM Shin, NF Saba, AK Smith, B Burtness, HS Park, ML Irwin, LM Ferrucci, B Ulrich, DC Qian, JJ Beitler, DW Bruner	09/01/2021
Defining HPV-specific B cell responses in patients with head and neck cancer. Nature	A Wieland, MR Patel, MA Cardenas, CS Eberhardt, WH Hudson, RC Obeng, CC Griffith, X Wang, ZG Chen, HT Kissick, NF Saba, R Ahmed	09/01/2021
Functional HPV-specific PD-1⁺ stem-like CD8 T cells in head and neck cancer. Nature	CS Eberhardt, HT Kissick, MR Patel, MA Cardenas, N Prokhnevska, RC Obeng, TH Nasti, CC Griffith, SJ Im, X Wang, DM Shin, M Carrington, ZG Chen, J Sidney, A Sette, NF Saba, A Wieland, R Ahmed	09/01/2021
Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1. Nature communications	C Pan, J Kang, JS Hwang, J Li, AC Boese, X Wang, L Yang, TJ Boggon, GZ Chen, NF Saba, DM Shin, KR Magliocca, L Jin, S Kang	08/16/2021
TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORS. Oral oncology	MR Patel, L Ottenstein, M Ryan, A Farrell, M Studer, HM Baddour, K Magliocca, C Griffith, W Stokes, J Switchenko, A Aiken, M El-Deiry, CA Solares, C Steuer, N Saba, J Beitler	06/01/2021
The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer	C Xiao, V Fedirko, J Beitler, J Bai, G Peng, C Zhou, J Gu, H Zhao, IH Lin, CE Chico, S Jeon, TM Knobf, KN Conneely, K Higgins, DM Shin, N Saba, A Miller, D Bruner	06/01/2021
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study. Cancers	CH Chung, M Bonomi, CE Steuer, J Li, P Bhateja, M Johnson, J Masannat, F Song, JC Hernandez-Prera, BM Wenig, H Molina, JM Farinhas, CP McMullen, JT Wadsworth, KB Patel, JA Kish, J Muzaffar, K Kirtane, JW Rocco, MJ Schell, NF Saba	03/09/2021
Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma. JCO oncology practice	JA Marks, JM Switchenko, CE Steuer, M Ryan, MR Patel, MW McDonald, K Higgins, JJ Beitler, DM Shin, TW Gillespie, NF Saba	03/01/2021
Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population. The Laryngoscope	A Tkaczuk, S Trivedi, MD Mody, CE Steuer, DM Shin, AM Klein, NF Saba	03/01/2021
Combinatorial approaches targeting the EGFR family and c-Met in SCCHN. Oral oncology	D Wang, Y Lu, S Nannapaneni, CC Griffith, C Steuer, G Qian, X Wang, Z Chen, M Patel, M El-Deiry, DM Shin, X He, ZG Chen, NF Saba	01/01/2021
Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma. PloS one	S Nannapaneni, CC Griffith, KR Magliocca, W Chen, X Lyu, Z Chen, D Wang, X Wang, DM Shin, ZG Chen, NF Saba	01/01/2021
Narrowband Imaging for p16+ Unknown Primary Squamous Cell Carcinoma Prior to Transoral Robotic Surgery. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery	K Al-Mulki, J Hamilton, AS Kaka, BJ Boyce, HM Baddour, M El-Deiry, CA Solares, K Magliocca, K Summers, A Aiken, NF Saba, JJ Beitler, MR Patel	12/01/2020
Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma. The Laryngoscope	DC Qian, KR Magliocca, AH Aiken, KL Baugnon, DC Brandon, WA Stokes, MW McDonald, MR Patel, HM Baddour, AS Kaka, CE Steuer, NF Saba, DM Shin, JJ Beitler	12/01/2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck. Clinical cancer research : an official journal of the American Association for Cancer Research	DM Shin, S Nannapaneni, MR Patel, Q Shi, Y Liu, Z Chen, AY Chen, MW El-Deiry, JJ Beitler, CE Steuer, SM Roser, AM Klein, TK Owonikoko, SS Ramalingam, FR Khuri, ZG Chen, NF Saba	11/15/2020
An update on the immune landscape in lung and head and neck cancers. CA: a cancer journal for clinicians	JW Carlisle, CE Steuer, TK Owonikoko, NF Saba	11/01/2020
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311. Oral oncology	RL Ferris, Y Flamand, FC Holsinger, GS Weinstein, H Quon, R Mehra, JJ Garcia, ML Hinni, ND Gross, EM Sturgis, U Duvvuri, E Méndez, JA Ridge, JS Magnuson, KA Higgins, MR Patel, RB Smith, DW Karakla, ME Kupferman, JP Malone, BL Judson, J Richmon, JO Boyle, R Bayon, BW O'Malley, E Ozer, GR Thomas, WM Koch, RB Bell, NF Saba, S Li, ER Sigurdson, B Burtness	11/01/2020
Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers. Cancers	J Bai, DW Bruner, V Fedirko, JJ Beitler, C Zhou, J Gu, H Zhao, IH Lin, CE Chico, KA Higgins, DM Shin, NF Saba, AH Miller, C Xiao	09/06/2020
Demographic and Socioeconomic Factors Associated With Metastases at Presentation in HPV-Related Squamous Cell Carcinoma of the Head and Neck: An NCDB Analysis. JCO oncology practice	MB Bean, JM Switchenko, CE Steuer, M Patel, K Higgins, M McDonald, GZ Chen, JJ Beitler, DM Shin, T Gillespie, NF Saba	06/01/2020
Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer. Psychosomatic medicine	C Xiao, RC Eldridge, JJ Beitler, KA Higgins, CE Chico, JC Felger, EC Wommack, T Knobf, NF Saba, DM Shin, DW Bruner, AH Miller	06/01/2020
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines	R Bommireddy, LE Munoz, A Kumari, L Huang, Y Fan, L Monterroza, CD Pack, S Ramachandiran, SJC Reddy, J Kim, ZG Chen, NF Saba, DM Shin, P Selvaraj	04/14/2020
Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups. Head & neck	S Tian, JM Switchenko, T Fei, RH Press, M Abugideiri, NF Saba, TK Owonikoko, AY Chen, JJ Beitler, WJ Curran, TW Gillespie, KA Higgins	04/01/2020
A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting. Molecular cancer therapeutics	L Shu, D Wang, NF Saba, ZG Chen	04/01/2020
Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC). PloS one	NF Saba, AR Dinasarapu, KR Magliocca, B Dwivedi, S Seby, ZS Qin, M Patel, CC Griffith, X Wang, M El-Deiry, CE Steuer, J Kowalski, DM Shin, ME Zwick, ZG Chen	01/01/2020
Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data. The oncologist	MB Bean, Y Liu, R Jiang, CE Steuer, M Patel, MW McDonald, KA Higgins, JJ Beitler, DM Shin, NF Saba	12/01/2019
Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database. Clinical lung cancer	S Tian, X Zhang, R Jiang, RN Pillai, TK Owonikoko, CE Steuer, NF Saba, S Pakkala, PR Patel, CP Belani, FR Khuri, WJ Curran, SS Ramalingam, M Behera, KA Higgins	11/01/2019
Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance. Molecular cancer therapeutics	NF Saba, ZG Chen, M Haigentz, P Bossi, A Rinaldo, JP Rodrigo, AA Mäkitie, RP Takes, P Strojan, JB Vermorken, A Ferlito	11/01/2019
Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation. The Journal of clinical investigation	C Pan, J Chun, D Li, AC Boese, J Li, J Kang, A Umano, Y Jiang, L Song, KR Magliocca, ZG Chen, NF Saba, DM Shin, TK Owonikoko, S Lonial, L Jin, S Kang	10/01/2019
Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma. Head & neck	S Tian, MJ Ferris, JM Switchenko, KR Magliocca, RJ Cassidy, J Jhaveri, AH Aiken, KL Baugnon, PA Hudgins, ATK Kendi, MR Patel, NF Saba, WJ Curran, JJ Beitler	09/01/2019
Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma. Head and neck pathology	GB Lesinski, S Nannapaneni, CC Griffith, M Patel, W Chen, Z Chen, R Ahmed, A Wieland, DM Shin, ZG Chen, NF Saba	09/01/2019
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial. The Lancet. Oncology	D Adkins, J Ley, P Neupane, F Worden, AG Sacco, K Palka, JE Grilley-Olson, R Maggiore, NN Salama, K Trinkaus, BA Van Tine, CE Steuer, NF Saba, P Oppelt	09/01/2019
Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base. Cancer	S Tian, JM Switchenko, J Jhaveri, RJ Cassidy, MJ Ferris, RH Press, NT Pfister, MR Patel, NF Saba, MW McDonald, KA Higgins, DS Yu, WJ Curran, TW Gillespie, JJ Beitler	08/15/2019
Small cell and large cell neuroendocrine carcinoma of the larynx: A comparative analysis. Cancer treatment reviews	P Strojan, JC Hernandez-Prera, JJ Beitler, A Eisbruch, NF Saba, WM Mendenhall, CS Nieto, R Smee, A Rinaldo, A Ferlito	08/01/2019
Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. The Journal of clinical investigation	C Pan, L Jin, X Wang, Y Li, J Chun, AC Boese, D Li, HB Kang, G Zhang, L Zhou, GZ Chen, NF Saba, DM Shin, KR Magliocca, TK Owonikoko, H Mao, S Lonial, S Kang	05/13/2019
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis. Head & neck	A Mohamed, B Twardy, MA Zordok, K Ashraf, A Alkhoder, K Schrapp, C Steuer, Z Chen, S Pakkala, R Pillai, J Trad Wadsworth, K Higgins, JJ Beitler, SS Ramalingam, TK Owonikoko, FR Khuri, DM Shin, M Behera, NF Saba	05/01/2019
Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal Cancer. American journal of clinical oncology	NF Saba, S Force, C Staley, F Fernandez, F Willingham, A Pickens, K Cardona, Z Chen, L Goff, D Cardin, E Lambright, J Nesbitt, A Krasinskas, K Higgins, RD Harvey, T Owonikoko, SS Ramalingam, DM Shin, JJ Beitler, BF El-Rayes, S Salaria, W El-Rifai, J Landry, AB Chakravarthy	04/01/2019
Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx. Cancer	JJ Beitler, JM Switchenko, JJ Dignam, MW McDonald, NF Saba, DM Shin, KR Magliocca, RJ Cassidy, MW El-Deiry, MR Patel, CE Steuer, C Xiao, PA Hudgins, AH Aiken, WJ Curran, QT Le	03/01/2019
Prognosis of subglottic carcinoma: Is it really worse? Head & neck	H Coskun, WM Mendenhall, A Rinaldo, JP Rodrigo, C Suárez, P Strojan, F López, V Mondin, NF Saba, AR Shaha, R Smee, RP Takes, A Ferlito	02/01/2019
Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas. The Laryngoscope	RJ Cassidy, JM Switchenko, MW El-Deiry, RH Belcher, J Zhong, CE Steuer, NF Saba, MW McDonald, DS Yu, TW Gillespie, JJ Beitler	02/01/2019
Prognostic implications of peritumoral vasculature in head and neck cancer. Cancer medicine	M Evans, HM Baddour, KR Magliocca, S Müller, S Nannapaneni, AY Chen, S Kim, Z Chen, DM Shin, AY Wang, NF Saba, ZG Chen	01/01/2019
Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma. Nutrition and cancer	LS Rozek, S Virani, EL Bellile, JMG Taylor, MA Sartor, KR Zarins, A Virani, C Cote, FP Worden, MEP Mark, SA McLean, SA Duffy, GH Yoo, NF Saba, DM Shin, O Kucuk, GT Wolf	01/01/2019
Racial Disparities, Outcomes, and Surgical Utilization among Hispanics with Esophageal Cancer: A Surveillance, Epidemiology, and End Results Program Database Analysis. Oncology	DR Gupta, Y Liu, R Jiang, S Walid, K Higgins, J Landry, M McDonald, FF Willingham, BF El-Rayes, NF Saba	01/01/2019
T4 Laryngeal Cancer With Good Function: Should We Be Reluctant to Treat Without Surgery? International journal of radiation oncology, biology, physics	JJ Beitler, JA Ridge, JB Vermorken, CR Bradford, P Strojan, NF Saba, C Suárez, JP Rodrigo, A Rinaldo, AY Chen, A Ferlito	12/01/2018
Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer. Brain, behavior, and immunity	C Xiao, JJ Beitler, KA Higgins, EC Wommack, NF Saba, DM Shin, DW Bruner, AH Miller, S Cole	11/01/2018
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial. JAMA oncology	RL Ferris, NF Saba, BJ Gitlitz, R Haddad, A Sukari, P Neupane, JC Morris, K Misiukiewicz, JE Bauman, M Fenton, A Jimeno, DR Adkins, CJ Schneider, AG Sacco, K Shirai, DW Bowles, M Gibson, T Nwizu, R Gottardo, KL Manjarrez, GN Dietsch, JK Bryan, RM Hershberg, EEW Cohen	11/01/2018
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer. The oncologist	ML Gillison, G Blumenschein, J Fayette, J Guigay, AD Colevas, L Licitra, KJ Harrington, S Kasper, EE Vokes, C Even, F Worden, NF Saba, LC Iglesias Docampo, R Haddad, T Rordorf, N Kiyota, M Tahara, M Monga, M Lynch, L Li, RL Ferris	09/01/2018
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation. Cancer cell	L Jin, J Chun, C Pan, D Li, R Lin, GN Alesi, X Wang, HB Kang, L Song, D Wang, G Zhang, J Fan, TJ Boggon, L Zhou, J Kowalski, CK Qu, CE Steuer, GZ Chen, NF Saba, LH Boise, TK Owonikoko, FR Khuri, KR Magliocca, DM Shin, S Lonial, S Kang	08/13/2018
Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer. Cancer	C Xiao, JJ Beitler, KA Higgins, T Glazer, LK Huynh, S Paul, JC Felger, EC Wommack, NF Saba, DM Shin, DW Bruner, AH Miller	08/01/2018
Time to Rethink Our Strategy With a Preoperative Intensification Approach. International journal of radiation oncology, biology, physics	NF Saba	07/15/2018
Systemic therapy in non-conventional cancers of the larynx. Oral oncology	E Tan, MD Mody, NF Saba	07/01/2018
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral oncology	RL Ferris, G Blumenschein, J Fayette, J Guigay, AD Colevas, L Licitra, KJ Harrington, S Kasper, EE Vokes, C Even, F Worden, NF Saba, LCI Docampo, R Haddad, T Rordorf, N Kiyota, M Tahara, M Lynch, V Jayaprakash, L Li, ML Gillison	06/01/2018
A Review of Photodynamic Therapy for Neoplasms of the Head and Neck. Advances in therapy	FJ Civantos, B Karakullukcu, M Biel, CE Silver, A Rinaldo, NF Saba, RP Takes, V Vander Poorten, A Ferlito	03/01/2018
A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma. Molecular cancer therapeutics	CE Steuer, CC Griffith, S Nannapaneni, MR Patel, Y Liu, KR Magliocca, MW El-Deiry, C Cohen, TK Owonikoko, DM Shin, ZG Chen, NF Saba	03/01/2018
Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin. Clinical cancer research : an official journal of the American Association for Cancer Research	X Wang, JJ Beitler, W Huang, G Chen, G Qian, K Magliocca, MR Patel, AY Chen, J Zhang, S Nannapaneni, S Kim, Z Chen, X Deng, NF Saba, ZG Chen, JL Arbiser, DM Shin	02/15/2018
Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome. Advances in therapy	A Coca-Pelaz, RP Takes, K Hutcheson, NF Saba, M Haigentz, CR Bradford, R de Bree, P Strojan, VJ Lund, WM Mendenhall, IJ Nixon, M Quer, A Rinaldo, A Ferlito	02/01/2018
Deformable Registration of Histological Cancer Margins to Gross Hyperspectral Images using Demons. Proceedings of SPIE--the International Society for Optical Engineering	M Halicek, JV Little, X Wang, ZG Chen, M Patel, CC Griffith, MW El-Deiry, NF Saba, AY Chen, B Fei	02/01/2018
Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer. ORL; journal for oto-rhino-laryngology and its related specialties	MR Patel, PA Hudgins, JJ Beitler, KR Magliocca, CC Griffith, Y Liu, K Bougnon, M El-Deiry, NF Saba, AH Aiken	01/01/2018
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma. Head & neck	H Zhang, S Kim, Z Chen, S Nannapaneni, AY Chen, CE Moore, G Sica, M Mosunjac, MLT Nguyen, G D'Souza, TE Carey, LA Peterson, JB McHugh, M Graham, CM Komarck, GT Wolf, HM Walline, E Bellile, J Riddell, SI Pai, D Sidransky, WH Westra, WN William, JJ Lee, AK El-Naggar, RL Ferris, R Seethala, JR Grandis, ZG Chen, NF Saba, DM Shin	12/01/2017
Refining the predictors of outcome in patients with resectable esophageal cancer. Cancer	NF Saba	11/01/2017
Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond. Head & neck	R de Bree, GT Wolf, B de Keizer, IJ Nixon, DM Hartl, AA Forastiere, M Haigentz, A Rinaldo, JP Rodrigo, NF Saba, C Suárez, JB Vermorken, A Ferlito	11/01/2017
Resilience and biomarkers of health risk in Black smokers and nonsmokers. Health psychology : official journal of the Division of Health Psychology, American Psychological Association	CJ Berg, R Haardörfer, CM McBride, V Kilaru, KJ Ressler, AP Wingo, NF Saba, JB Payne, A Smith	11/01/2017
The Impact of Histologic Phenotype in the Treatment of Sinonasal Cancer. Advances in therapy	F López, VJ Lund, C Suárez, CH Snyderman, NF Saba, KT Robbins, V Vander Poorten, P Strojan, WM Mendenhall, A Rinaldo, A Ferlito	10/01/2017
Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base. Cancer	KB Naik, Y Liu, M Goodman, TW Gillespie, A Pickens, SD Force, CE Steuer, TK Owonikoko, SS Ramalingam, K Higgins, JJ Beitler, DM Shin, FF Willingham, B El-Rayes, JC Landry, FG Fernandez, NF Saba	09/15/2017
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review. JAMA oncology	CE Steuer, M Behera, V Ernani, KA Higgins, NF Saba, DM Shin, S Pakkala, RN Pillai, TK Owonikoko, WJ Curran, CP Belani, FR Khuri, SS Ramalingam	08/01/2017
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. The Lancet. Oncology	KJ Harrington, RL Ferris, G Blumenschein, AD Colevas, J Fayette, L Licitra, S Kasper, C Even, EE Vokes, F Worden, NF Saba, N Kiyota, R Haddad, M Tahara, V Grünwald, JW Shaw, M Monga, M Lynch, F Taylor, M DeRosa, L Morrissey, K Cocks, ML Gillison, J Guigay	08/01/2017
Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy. Critical reviews in oncology/hematology	NF Saba, MD Mody, ES Tan, HS Gill, A Rinaldo, RP Takes, P Strojan, DM Hartl, JB Vermorken, M Haigentz, A Ferlito	07/01/2017
How phenotype guides management of non-conventional squamous cell carcinomas of the larynx? European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery	F López, MD Williams, A Cardesa, JL Hunt, P Strojan, A Rinaldo, IJ Nixon, JP Rodrigo, NF Saba, WM Mendenhall, M Quer, C Suárez, A Ferlito	07/01/2017
Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma. AJNR. American journal of neuroradiology	DA Krieger, PA Hudgins, GK Nayak, KL Baugnon, AS Corey, MR Patel, JJ Beitler, NF Saba, Y Liu, AH Aiken	06/01/2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	J Bauml, TY Seiwert, DG Pfister, F Worden, SV Liu, J Gilbert, NF Saba, J Weiss, L Wirth, A Sukari, H Kang, MK Gibson, E Massarelli, S Powell, A Meister, X Shu, JD Cheng, R Haddad	05/10/2017
Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non-Small-Cell Lung Cancer. Clinical lung cancer	NF Saba, Y Wang, H Fu, L Koenig, FR Khuri, DM Shin, ZG Chen	05/01/2017
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base. Clinical lung cancer	CE Steuer, M Behera, Y Liu, C Fu, TW Gillespie, NF Saba, DM Shin, RN Pillai, S Pakkala, TK Owonikoko, FR Khuri, SS Ramalingam	05/01/2017
Nasal juvenile angiofibroma: Current perspectives with emphasis on management. Head & neck	F López, A Triantafyllou, CH Snyderman, JL Hunt, C Suárez, VJ Lund, P Strojan, NF Saba, IJ Nixon, KO Devaney, I Alobid, M Bernal-Sprekelsen, EY Hanna, A Rinaldo, A Ferlito	05/01/2017
Otorhinolaryngological Toxicities of New Drugs in Oncology. Advances in therapy	DM Hartl, D Morel, E Saavedra, C Massard, A Rinaldo, NF Saba, A Ferlito, JC Soria	04/01/2017
Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers. JAMA otolaryngology-- head & neck surgery	RJ Cassidy, JM Switchenko, N Jegadeesh, M Sayan, MJ Ferris, BR Eaton, KA Higgins, JT Wadsworth, KR Magliocca, NF Saba, JJ Beitler	04/01/2017
ACR appropriateness criteria^® nasal cavity and paranasal sinus cancers. Head & neck	F Siddiqui, RV Smith, SS Yom, JJ Beitler, PM Busse, JS Cooper, EY Hanna, CU Jones, SA Koyfman, H Quon, JA Ridge, NF Saba, F Worden, M Yao, JK Salama	03/01/2017
CT Accuracy of Extrinsic Tongue Muscle Invasion in Oral Cavity Cancer. AJNR. American journal of neuroradiology	JC Junn, KL Baugnon, EA Lacayo, PA Hudgins, MR Patel, KR Magliocca, AS Corey, M El-Deiry, JT Wadsworth, JJ Beitler, NF Saba, Y Liu, AH Aiken	02/01/2017
Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials. Auris, nasus, larynx	A Sanabria, ALF Chaves, LP Kowalski, GT Wolf, NF Saba, AA Forastiere, JJ Beitler, KI Nibu, CR Bradford, C Suárez, JP Rodrigo, P Strojan, A Rinaldo, R de Bree, M Haigentz, RP Takes, A Ferlito	02/01/2017
HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models. Clinical cancer research : an official journal of the American Association for Cancer Research	D Wang, G Qian, H Zhang, KR Magliocca, S Nannapaneni, AR Amin, M Rossi, M Patel, M El-Deiry, JT Wadsworth, Z Chen, FR Khuri, DM Shin, NF Saba, ZG Chen	02/01/2017
Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study. American journal of nuclear medicine and molecular imaging	AT Kendi, D Brandon, J Switchenko, JT Wadsworth, MW El-Deiry, NF Saba, DM Schuster, RM Subramaniam	01/01/2017
An update on larynx cancer. CA: a cancer journal for clinicians	CE Steuer, M El-Deiry, JR Parks, KA Higgins, NF Saba	01/01/2017
Commentary: Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study). Frontiers in oncology	NF Saba	01/01/2017
Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare Tumor. Oncology	M Evans, Y Liu, C Chen, C Steuer, R Cassidy, J Landry, K Higgins, JJ Beitler, F Willingham, TK Owonikoko, SS Ramalingam, DM Shin, NK Jegadeesh, B El-Rayes, F Fernandez, AM Krasinskas, T Gillespie, NF Saba	01/01/2017
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Cancer	A Jimeno, MR Posner, LJ Wirth, NF Saba, RB Cohen, EC Popa, A Argiris, KF Grossmann, A Sukari, D Wilson, X Zhang, J Sun, C Glasser, KM Attie, ML Sherman, SS Pandya, J Weiss	12/01/2016
The Future Prospects of Immune Therapy in Gastric and Esophageal Adenocarcinoma. Journal of clinical medicine	WL Shaib, JP Nammour, H Gill, M Mody, NF Saba	11/14/2016
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. The New England journal of medicine	RL Ferris, G Blumenschein, J Fayette, J Guigay, AD Colevas, L Licitra, K Harrington, S Kasper, EE Vokes, C Even, F Worden, NF Saba, LC Iglesias Docampo, R Haddad, T Rordorf, N Kiyota, M Tahara, M Monga, M Lynch, WJ Geese, J Kopit, JW Shaw, ML Gillison	11/10/2016
Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we? European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery	SE Samuels, A Eisbruch, JJ Beitler, J Corry, CR Bradford, NF Saba, MW van den Brekel, R Smee, P Strojan, C Suárez, WM Mendenhall, RP Takes, JP Rodrigo, M Haigentz, AD Rapidis, A Rinaldo, A Ferlito	10/01/2016
Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors? AJR. American journal of roentgenology	AT Kendi, KR Magliocca, A Corey, JR Galt, J Switchenko, JT Wadsworth, MW El-Deiry, DM Schuster, NF Saba, PA Hudgins	09/01/2016
Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation. European journal of cancer (Oxford, England : 1990)	G Qian, D Wang, KR Magliocca, Z Hu, S Nannapaneni, S Kim, Z Chen, SY Sun, DM Shin, NF Saba, ZG Chen	09/01/2016
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Head & neck	JJ Beitler, H Quon, CU Jones, JK Salama, PM Busse, JS Cooper, SA Koyfman, JA Ridge, NF Saba, F Siddiqui, RV Smith, F Worden, M Yao, SS Yom	09/01/2016
The Challenges of Laryngeal Preservation-Is It the Systemic Agent or the Proper Sequence of Therapy? JAMA otolaryngology-- head & neck surgery	NF Saba, DM Shin	09/01/2016
The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review. JAMA otolaryngology-- head & neck surgery	MD Mody, HS Gill, NF Saba	09/01/2016
Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement. Cancer	AM Gamboa, S Kim, SD Force, CA Staley, KE Woods, DA Kooby, SK Maithel, JA Luke, KM Shaffer, S Dacha, NF Saba, SA Keilin, Q Cai, BF El-Rayes, Z Chen, FF Willingham	07/15/2016
Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer. Oncotarget	Z Hu, G Qian, S Müller, J Xu, NF Saba, S Kim, Z Chen, N Jiang, D Wang, H Zhang, K Lane, C Hoyt, DM Shin, ZG Chen	07/12/2016
ACR Appropriateness criteria® for nasopharyngeal carcinoma. Head & neck	NF Saba, JK Salama, JJ Beitler, PM Busse, JS Cooper, CU Jones, S Koyfman, H Quon, JA Ridge, F Siddiqui, F Worden, M Yao, SS Yom	07/01/2016
Dual Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibition in Squamous Cell Carcinoma of the Head and Neck; Is the Jury Still Out? Journal of clinical oncology : official journal of the American Society of Clinical Oncology	NF Saba, SJ Wong	06/10/2016
Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy. Head & neck	S Hanasoge, KR Magliocca, JM Switchenko, NF Saba, JT Wadsworth, MW El-Deiry, DM Shin, F Khuri, JJ Beitler, KA Higgins	06/01/2016
Impact of neck failure on survival in older patients with differentiated thyroid cancer. Head & neck	DM Marcus, R Jiang, KC Ward, KA Higgins, NF Saba, JT Wadsworth, JJ Beitler	06/01/2016
Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer. Journal of translational medicine	TK Owonikoko, G Zhang, HS Kim, RM Stinson, R Bechara, C Zhang, Z Chen, NF Saba, S Pakkala, R Pillai, X Deng, SY Sun, MR Rossi, GL Sica, SS Ramalingam, FR Khuri	05/03/2016
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review. Head & neck	P Strojan, JB Vermorken, JJ Beitler, NF Saba, M Haigentz, P Bossi, FP Worden, JA Langendijk, A Eisbruch, WM Mendenhall, AW Lee, LB Harrison, CR Bradford, R Smee, CE Silver, A Rinaldo, A Ferlito	04/01/2016
Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer	T McKibbin, LL Cheng, S Kim, CE Steuer, TK Owonikoko, FR Khuri, DM Shin, NF Saba	04/01/2016
Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation? Annals of translational medicine	CH Chapman, NF Saba, SS Yom	02/01/2016
Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy. Brain, behavior, and immunity	C Xiao, JJ Beitler, KA Higgins, K Conneely, B Dwivedi, J Felger, EC Wommack, DM Shin, NF Saba, LY Ong, J Kowalski, DW Bruner, AH Miller	02/01/2016
Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration? European journal of radiology	AT Kendi, A Corey, KR Magliocca, JR Galt, C Zhang, Z Chen, K Higgins, JJ Beitler, JT Wadsworth, MW El-Deiry, DM Schuster, NF Saba, PA Hudgins	02/01/2016
ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. Head & neck	SA Koyfman, JS Cooper, JJ Beitler, PM Busse, CU Jones, MW McDonald, H Quon, JA Ridge, NF Saba, JK Salama, F Siddiqui, RV Smith, F Worden, M Yao, SS Yom	02/01/2016
Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005. Cancer	M Behera, C Ragin, S Kim, RN Pillai, Z Chen, CE Steuer, NF Saba, CP Belani, FR Khuri, SS Ramalingam, TK Owonikoko	01/01/2016
Complete Remission of Acute Myeloid Leukemia following Cisplatin Based Concurrent Therapy with Radiation for Squamous Cell Laryngeal Cancer. Case reports in hematology	MD Mody, HS Gill, KA Higgins, NF Saba, VK Kota	01/01/2016
Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy. Frontiers in oncology	M Sayan, RJ Cassidy, JM Switchenko, OA Kayode, NF Saba, CE Steuer, DM Shin, JT Wadsworth, M El-Deiry, M Patel, JJ Beitler, KA Higgins	01/01/2016
Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline. PloS one	D Wang, S Peng, AR Amin, MA Rahman, S Nannapaneni, Y Liu, DM Shin, NF Saba, JF Eichler, ZG Chen	01/01/2016
The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer treatment reviews	P Bossi, NF Saba, JB Vermorken, P Strojan, L Pala, R de Bree, JP Rodrigo, F Lopez, EY Hanna, M Haigentz, RP Takes, PJ Slootweg, CE Silver, A Rinaldo, A Ferlito	12/01/2015
Targeting HER (ERBB) signaling in head and neck cancer: An essential update. Molecular aspects of medicine	J Zhang, NF Saba, GZ Chen, DM Shin	11/01/2015
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma. Cancer	G Qian, N Jiang, D Wang, S Newman, S Kim, Z Chen, G Garcia, G MacBeath, DM Shin, FR Khuri, ZG Chen, NF Saba	10/15/2015
Current treatment of T1N0 squamous cell carcinoma of the glottic larynx. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery	WM Mendenhall, RP Takes, JP Shah, PJ Bradley, JJ Beitler, P Strojan, C Suárez, JP Rodrigo, NF Saba, A Rinaldo, JA Werner, A Ferlito	08/01/2015
Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic Review. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer	M Behera, RN Pillai, TK Owonikoko, S Kim, C Steuer, Z Chen, NF Saba, CP Belani, FR Khuri, SS Ramalingam	08/01/2015
Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2. Apoptosis : an international journal on programmed cell death	A Haque, MA Rahman, ZG Chen, NF Saba, FR Khuri, DM Shin, AR Ruhul Amin	07/01/2015
18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers? European journal of radiology	AT Kendi, A Corey, KR Magliocca, DC Nickleach, J Galt, JM Switchenko, MW El-Deiry, JT Wadsworth, PA Hudgins, NF Saba, DM Schuster	06/01/2015
Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head & neck	RS Prabhu, S Hanasoge, KR Magliocca, WA Hall, SA Chen, KA Higgins, NF Saba, M El-Deiry, W Grist, JT Wadsworth, AY Chen, JJ Beitler	06/01/2015
Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle. Head and neck pathology	NF Saba, M Wilson, G Doho, J DaSilva, R Benjamin Isett, S Newman, ZG Chen, K Magliocca, MR Rossi	06/01/2015
Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis. Oral oncology	LJ Joseph, M Goodman, K Higgins, R Pilai, SS Ramalingam, K Magliocca, MR Patel, M El-Deiry, JT Wadsworth, TK Owonikoko, JJ Beitler, FR Khuri, DM Shin, NF Saba	06/01/2015
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research	TK Owonikoko, SS Ramalingam, DL Miller, SD Force, GL Sica, J Mendel, Z Chen, A Rogatko, M Tighiouart, RD Harvey, S Kim, NF Saba, A Pickens, M Behera, RW Fu, MR Rossi, WF Auffermann, WE Torres, R Bechara, X Deng, SY Sun, H Fu, AA Gal, FR Khuri	04/15/2015
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research	TJ Galloway, LJ Wirth, AD Colevas, J Gilbert, JE Bauman, NF Saba, D Raben, R Mehra, AW Ma, R Atoyan, J Wang, B Burtness, A Jimeno	04/01/2015
Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis. Lung cancer (Amsterdam, Netherlands)	CE Steuer, M Behera, S Kim, N Patel, Z Chen, R Pillai, NF Saba, DM Shin, TK Owonikoko, FR Khuri, SS Ramalingam	04/01/2015
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma. Oral oncology	J Gilbert, MJ Schell, X Zhao, B Murphy, T Tanvetyanon, ME Leon, D Neil Hayes, M Haigentz, N Saba, J Nieva, J Bishop, D Sidransky, R Ravi, A Bedi, CH Chung	04/01/2015
Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status? Clinical nuclear medicine	AT Kendi, K Magliocca, A Corey, DC Nickleach, J Galt, K Higgins, JJ Beitler, MW El-Deiry, JT Wadsworth, PA Hudgins, NF Saba, DM Schuster	03/01/2015
Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer	CE Steuer, M Behera, S Kim, Z Chen, NF Saba, RN Pillai, TK Owonikoko, FR Khuri, SS Ramalingam	03/01/2015
Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention". Oral oncology	NF Saba, M Haigentz, JB Vermorken, P Strojan, P Bossi, A Rinaldo, RP Takes, A Ferlito	02/01/2015
Human papillomavirus 16 oncoprotein regulates the translocation of β-catenin via the activation of epidermal growth factor receptor. Cancer	Z Hu, S Müller, G Qian, J Xu, S Kim, Z Chen, N Jiang, D Wang, H Zhang, NF Saba, DM Shin, ZG Chen	01/15/2015
Oral Cavity Cancer: Risk Factors, Pathology, and Management. Oncology	V Ernani, NF Saba	01/01/2015
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck. Cancer	NF Saba, SJ Hurwitz, K Magliocca, S Kim, TK Owonikoko, D Harvey, SS Ramalingam, Z Chen, J Rogerio, J Mendel, SA Kono, C Lewis, AY Chen, K Higgins, M El-Deiry, T Wadsworth, JJ Beitler, DM Shin, SY Sun, FR Khuri	12/15/2014
Pre-medications for cetuximab induced infusion reactions - commentary. Oral oncology	T McKibbin, R Donald Harvey, NF Saba	12/01/2014
Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation. Cancer chemotherapy and pharmacology	K Patel, J Wen, K Magliocca, S Muller, Y Liu, ZG Chen, N Saba, R Diaz	11/01/2014
Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review. Oral oncology	M Behera, TK Owonikoko, S Kim, Z Chen, K Higgins, SS Ramalingam, DM Shin, FR Khuri, JJ Beitler, NF Saba	09/01/2014
Targeted therapies in metastatic esophageal cancer: advances over the past decade. Critical reviews in oncology/hematology	A Mohamed, B El-Rayes, FR Khuri, NF Saba	08/01/2014
Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma. Molecular cancer therapeutics	N Jiang, D Wang, Z Hu, HJ Shin, G Qian, MA Rahman, H Zhang, AR Amin, S Nannapaneni, X Wang, Z Chen, G Garcia, G MacBeath, DM Shin, FR Khuri, J Ma, ZG Chen, NF Saba	07/01/2014
ACR Appropriateness Criteria® thyroid carcinoma. Oral oncology	JK Salama, DW Golden, SS Yom, MK Garg, J Lawson, MW McDonald, H Quon, JA Ridge, N Saba, RV Smith, F Worden, AR Yeung, JJ Beitler	06/01/2014
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study. Cancer prevention research (Philadelphia, Pa.)	NF Saba, SJ Hurwitz, SA Kono, CS Yang, Y Zhao, Z Chen, G Sica, S Müller, R Moreno-Williams, M Lewis, W Grist, AY Chen, CE Moore, TK Owonikoko, S Ramalingam, JJ Beitler, S Nannapaneni, HJ Shin, JR Grandis, FR Khuri, ZG Chen, DM Shin	03/01/2014
Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck. Head and neck pathology	NF Saba, KR Magliocca, S Kim, S Muller, Z Chen, TK Owonikoko, NJ Sarlis, C Eggers, V Phelan, WJ Grist, AY Chen, SS Ramalingam, ZG Chen, JJ Beitler, DM Shin, FR Khuri, AI Marcus	03/01/2014
American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer. Head & neck	JA Ridge, J Lawson, SS Yom, MK Garg, MW McDonald, H Quon, N Saba, JK Salama, RV Smith, F Worden, AR Yeung, JJ Beitler	01/01/2014
Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection. International journal of radiation oncology, biology, physics	RS Prabhu, KR Magliocca, S Hanasoge, AH Aiken, PA Hudgins, WA Hall, SA Chen, BR Eaton, KA Higgins, NF Saba, JJ Beitler	01/01/2014
Incidence and prognosis of gastroesophageal cancer in rural, urban, and metropolitan areas of the United States. Cancer	Z Wang, M Goodman, N Saba, BF El-Rayes	11/15/2013
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009. Cancer	B Ansa, M Goodman, K Ward, SA Kono, TK Owonikoko, K Higgins, JJ Beitler, W Grist, T Wadsworth, M El-Deiry, AY Chen, FR Khuri, DM Shin, NF Saba	07/15/2013
Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma. Journal of gastrointestinal cancer	JS Carr, SF Zafar, N Saba, FR Khuri, BF El-Rayes	06/01/2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies. Clinical cancer research : an official journal of the American Association for Cancer Research	DM Shin, H Zhang, NF Saba, AY Chen, S Nannapaneni, AR Amin, S Müller, M Lewis, G Sica, S Kono, JC Brandes, WJ Grist, R Moreno-Williams, JJ Beitler, SM Thomas, Z Chen, HJ Shin, JR Grandis, FR Khuri, ZG Chen	03/01/2013
Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer. Head & neck	MK Garg, JA Ridge, SS Yom, MW McDonald, H Quon, RV Smith, AR Yeung, J Lawson, N Saba, JK Salama, JJ Beitler	03/01/2013
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer	SS Ramalingam, TK Owonikoko, M Behera, J Subramanian, NF Saba, SA Kono, AA Gal, G Sica, RD Harvey, Z Chen, CM Klass, DM Shin, H Fu, SY Sun, R Govindan, FR Khuri	03/01/2013
Clinical efficacy of targeted biologic agents as second-line therapy of advanced thyroid cancer. The oncologist	TK Owonikoko, RP Chowdry, Z Chen, S Kim, NF Saba, DM Shin, FR Khuri	01/01/2013
Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis. The oncologist	TK Owonikoko, C Ragin, Z Chen, S Kim, M Behera, JC Brandes, NF Saba, R Pentz, SS Ramalingam, FR Khuri	01/01/2013
Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer	CL Ellington, M Goodman, SA Kono, W Grist, T Wadsworth, AY Chen, T Owonikoko, S Ramalingam, DM Shin, FR Khuri, JJ Beitler, NF Saba	09/15/2012
HPV positive squamous cell carcinoma of the oropharynx. Are we observing an unusual pattern of metastases? Head and neck pathology	S Müller, FR Khuri, SA Kono, JJ Beitler, DM Shin, NF Saba	09/01/2012
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer. European journal of cancer (Oxford, England : 1990)	J Xu, S Müller, S Nannapaneni, L Pan, Y Wang, X Peng, D Wang, M Tighiouart, Z Chen, NF Saba, JJ Beitler, DM Shin, ZG Chen	07/01/2012
Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy. Cancer	S Pakkala, Z Chen, D Rimland, TK Owonikoko, C Gunthel, JR Brandes, NR Saba, DM Shin, WJ Curran, FR Khuri, SS Ramalingam	01/01/2012
Advances in Targeting HER3 as an Anticancer Therapy. Chemotherapy research and practice	N Jiang, NF Saba, ZG Chen	01/01/2012
EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab. Chemotherapy research and practice	SA Kono, M Haigentz, SS Yom, N Saba	01/01/2012
Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors. Chemotherapy research and practice	NF Saba, SS Yom, M Haigentz, B El-Rayes	01/01/2012
Antiepidermal growth factor receptor therapy in squamous cell carcinoma of the head and neck. Journal of oncology	W Shaib, S Kono, N Saba	01/01/2012
Patterns of extralaryngeal spread of laryngeal cancer: thyroid cartilage penetration occurs in a minority of patients with extralaryngeal spread of laryngeal squamous cell cancers. Cancer	SA Chen, S Muller, AY Chen, PA Hudgins, DM Shin, F Khuri, NF Saba, JJ Beitler	11/15/2011
Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies. Cancer	J Kauh, C Chanel-Vos, D Escuin, MP Fanucchi, RD Harvey, N Saba, DM Shin, A Gal, L Pan, M Kutner, SS Ramalingam, L Bender, A Marcus, P Giannakakou, FR Khuri	09/01/2011
ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. International journal of radiation oncology, biology, physics	MW McDonald, J Lawson, MK Garg, H Quon, JA Ridge, N Saba, JK Salama, RV Smith, AR Yeung, SS Yom, JJ Beitler	08/01/2011
Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology	NF Saba, M Goodman, K Ward, C Flowers, S Ramalingam, T Owonikoko, A Chen, W Grist, T Wadsworth, JJ Beitler, FR Khuri, DM Shin	01/01/2011
Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer. Cancer	SS Ramalingam, RD Harvey, N Saba, TK Owonikoko, J Kauh, DM Shin, SY Sun, S Strychor, M Tighiouart, MJ Egorin, H Fu, FR Khuri	08/15/2010
ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas. Current problems in cancer	H Quon, SS Yom, MK Garg, J Lawson, MW McDonald, JA Ridge, N Saba, J Salama, R Smith, AR Yeung, JJ Beitler	01/01/2010
Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis. Head & neck	NF Saba, S Edelman, M Tighiouart, J Gaultney, LW Davis, FR Khuri, A Chen, W Grist, DM Shin	11/01/2009
Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma. Cancer prevention research (Philadelphia, Pa.)	NF Saba, M Choi, S Muller, HJ Shin, M Tighiouart, VA Papadimitrakopoulou, AK El-Naggar, FR Khuri, ZG Chen, DM Shin	09/01/2009
Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents. Current opinion in oncology	NF Saba, FR Khuri	05/01/2009
Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug. Head & neck	NF Saba, X Wang, S Müller, M Tighiouart, K Cho, S Nie, Z Chen, DM Shin	04/01/2009
Percutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation. American journal of otolaryngology	JD Lawson, J Gaultney, N Saba, W Grist, L Davis, PA Johnstone	01/01/2009
Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer	S Muller, L Su, M Tighiouart, N Saba, H Zhang, DM Shin, Z Chen	07/01/2008

Awards

Atlanta Magazine's "Top Doctors", 2005, 2016-2023
Outstanding reviewer for journal, Cancer, 2017
Castle Connolly Top Doctors, 2011 and 2014
Distinguished Doctor, Expert Network, 2015
Recognition for outstanding contribution to the Fellowship program, University of Minnesota, Hematology Oncology and transplant section, 2003
Dean's Honor List, American University of Beirut, 1984-1990

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.7	One star One star One star One star One half star	Provider showed concern
4.6	One star One star One star One star One half star	Provider explained things clearly
4.6	One star One star One star One star One half star	Provider discussed treatment options
4.6	One star One star One star One star One half star	Provider included you in decisions
4.6	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	11/16/2024	Dr Saba was excellent
One star One star One star One star One star	08/16/2024	Dr Saba was so patient explaining the lab results. He made it understandable.
One star One star One half star Empty star Empty star	08/09/2024	I brought up concerns regarding side effects and treatment options, they were not volunteered by Dr Saba, in fact I felt dismissed with my concerns
One star One star One star One star One star	08/01/2024	Dr. Saba very friendly, warm and caring. He Always addresses all of my concerns and will go over any type of procedure in a very detailed manner that is easy to understand. I would definitely 100% recommend any of the physicians that have treated me at Winship to any of my family or friends.
One star One star One star One star One star	07/30/2024	Emory Is exceptional In every way
One star One star One star One star One star	07/13/2024	Dr. Saba gave me good responses to my plan to see if I would be okay for thyroid surgery. Then he helped arrange for a CT scan appointment for me before I see the Emory surgeon.
One star One star One star One star One star	06/20/2024	It was all good news.
One star One star One star One star One half star	06/18/2024	It was a good initial visit.
One star One star One star Empty star Empty star	06/15/2024	It was just a lot to take in, but we understood the Doctor was saying overall about the treatment and hopefully the out come .
One star One star One star Empty star Empty star	05/02/2024	Dr'did not offer any specific info for patient with critical cancer. Did not answer all questions and stated I would be called to set up appt next week. Was not called and happened to see appt on My Chart. Appt was not set for the next week as stated but the following week.
One star One star One half star Empty star Empty star	05/01/2024	Seems like members of the team didn't know what each other was doing
One star Empty star Empty star Empty star Empty star	04/09/2024	Bad
One star One star One star One star One star	04/04/2024	Had an excellent report
One star One star One star One star One star	02/21/2024	No bad experience.
One star One star One star One star One half star	01/11/2024	As always Dr Saba is up front about my cancer.
One star One star One star One star One star	12/09/2023	Really liked Dr Saba
One star One star One star One star One star	12/06/2023	I felt relief from some worries I was having.
One star One star One star One star One star	11/17/2023	I was given great news.
One star One star One star One star One half star	11/14/2023	Good
One star One star One star One star One star	11/02/2023	Good
One star One star One star One star One star	10/31/2023	Doc. Saba was very much in sync with my prognosis. I understand the plan of action.
One star One star One star One star One half star	10/07/2023	Dr Saba very good- would like to see him at every appt
One star One star One star One star One star	09/28/2023	They gave me a great consultation
One star One star One star One star One star	09/22/2023	Dr. Saba is exceptional. I would travel great distances and go to great personal inconvenience to be able to receive the care he provides.
One star One star One star One star One star	09/12/2023	I wouldn't care to go anywhere else but Emory.
One star One star One star One star One star	08/26/2023	Excellent Dr Saba is a Great Professional Doctor
One star One star One star One star One star	06/22/2023	Very good information/instructions from Dr. Saba. I felt better after seeing the Doctor.
One star One star One star One star One star	06/22/2023	Dr. Saba is an awesome doctor, very helpful, kind & friendly.
One star One star One star One star One star	05/04/2023	Dr. Saba is a rare mix of extensive medical knowledge, experience, and a caring person. We respect him but also like him a lot too. We also feel this way about Annette.
One star One star One star One star One star	03/29/2023	Dr. Saba is very professional but also personal as well.
One star One star One star One star One star	03/01/2023	Doctor Saba is informative and instills confidence. I feel I can trust his judgement and that he listens to my opinion and concerns.
One star One star One star One star One star	02/04/2023	Dr. Saba explained that he believes the treatments are working for me. He also relieved my mind by letting me know that the small spot they see is nothing of concern! It's too small to tell what it as It's apparent there Is no change. They have been seeing it on several scans but I'm confident in Dr. Saba's assessment.
One star One star One star One star One star	12/15/2022	Excellent communication